
Adaptimmune Therapeutics PLC
ADAPYOTCCIK 1621227HealthcareFiscal year ends Dec 31
Reports and events: 279 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2017-05-2516:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-035235 |
| 2017-05-1616:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-033194 |
| 2017-05-1011:47 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001104659-17-031428 |
| 2017-05-1007:38 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-031339 |
| 2017-04-2816:48 ET | DEF 14A | Proxy statementPeriod 2017-06-21 | 0001047469-17-003061 |
| 2017-04-1016:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-022631 |
| 2017-04-0616:39 ET | 10-Q/A | Quarterly report, amendedPeriod 2016-09-30 | 0001104659-17-021990 |
| 2017-04-0509:12 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-021562 |
| 2017-03-3012:50 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-020261 |
| 2017-03-2217:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-17-018638 |
| 2017-03-1516:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-17-016654 |
| 2017-03-1416:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-17-016387 |
| 2017-03-1312:51 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001104659-17-016024 |
| 2017-03-1307:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-17-015968 |
| 2017-01-0912:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-17-001464 |
| 2017-01-0908:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-17-001373 |
| 2016-12-1917:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-162841 |
| 2016-12-0507:48 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-16-160502 |
| 2016-11-2516:30 ET | 8-K | 1.02 Termination of a material agreement | 0001104659-16-159106 |
| 2016-11-1406:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-156438 |
| 2016-11-1009:29 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001104659-16-156035 |
| 2016-11-1006:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-16-155987 |
| 2016-11-0916:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-16-155869 |
| 2016-11-0816:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-16-155574 |
| 2016-10-2716:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-16-152603 |
| 2016-10-2716:29 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-152602 |
| 2016-10-1808:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-150614 |
| 2016-10-1216:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-149817 |
| 2016-09-2607:41 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-146421 |
| 2016-09-1907:40 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-145324 |
| 2016-08-1216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-16-139355 |
| 2016-08-0811:14 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001104659-16-137807 |
| 2016-08-0807:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-16-137733 |
| 2016-08-0420:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-16-136699 |
| 2016-07-0816:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-16-131771 |
| 2016-06-2316:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-16-129072 |
| 2016-06-2107:49 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-128496 |
| 2016-06-2011:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-128237 |
| 2016-06-1606:50 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-16-127557 |
| 2016-06-0609:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-125544 |
| 2016-05-2409:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-16-122829 |
| 2016-05-1211:01 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001104659-16-120341 |
| 2016-05-1208:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-16-120271 |
| 2016-04-2916:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-116263 |
| 2016-04-2212:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-113452 |
| 2016-04-2208:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-113388 |
| 2016-04-1516:45 ET | 8-K | 8.01 Other events | 0001104659-16-111860 |
| 2016-04-0714:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-110316 |
| 2016-03-3008:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-108482 |
| 2016-03-1708:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-16-105692 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.